Wird geladen...
The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
Dopamine agonists such as bromocriptine and cabergoline are the predominant treatment drugs for prolactinoma by inhibiting prolactin secretion and shrinking tumor size. However, the pathways of either dopamine or its agonists that lead to the death of cells are incompletely understood and some are e...
Gespeichert in:
| Veröffentlicht in: | Front Endocrinol (Lausanne) |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357924/ https://ncbi.nlm.nih.gov/pubmed/30740089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00768 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|